{
  "hash": "302db9cc9490243e4948f0320f02e013",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: Preferred medications for opioid agonist therapy and associated factors among people who regularly use opioids in Australia\nauthor:\n  - name: MJ Stowe\n    orcid: 0000-0002-0760-5497\n    corresponding: true\n    email: mjstowe@kirby.unsw.edu.au\n    roles:\n      - Investigation\n      - Project administration\n      - Software\n      - Visualization\n    affiliations:\n      - The Kirby Institute, UNSW Syndey, Sydney Australia\n  - name: Anna Conway\n    orcid: 0000-0002-7859-8394\n    corresponding: false\n    roles: []\n    affiliations:\n      - The Kirby Institute, UNSW Syndey, Sydney Australia\nkeywords:\n  - Opioid agonist therapy\n  - Medications for opioid use disorder\n  - Methadone\n  - Burpenorphine\nabstract: |                                                                                          \n  **Background:** People who use opioids from an unregulated drug supply are increasingly exposed to related adverse social and health outcomes. Opioid agonist therapy (OAT) is effective in mitigating adverse outcomes, with individual preference identified as key to enhancing treatment.\n\nplain-language-summary: |\n  In a national sample of people who regularly use opioids, most preferred OAT with methadone. These participants were more likely to have ever received methadone, and have previously used heroin or non-prescrived pharmaceuticals. Among participants currently receiving OAT, almost all were receiving their preferred therapy.\ndate: last-modified\ncss: custom01.css\nbibliography: references.bib\ncitation:\n  container-title: Patient Preferences\nnumber-sections: true\n---\n\n\n## Introduction\n\n## Data & Methods {#sec-data-methods}\n\n\n::: {.cell .hidden}\n\n```{.r .cell-code .hidden}\nknitr::opts_chunk$set(echo=FALSE, include = FALSE, fig.align = \"center\")\n```\n:::\n\n::: {.cell .hidden layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n# Load the packages required for the analysis. If packages haven't been installed yet, use install.packages() followed by the library() function.\n# \n# Another way to load packages is through the pacman package using the p_load() function.\n\npacman::p_load(\n   pacman, \n   ggplot2,    # plotting and graphing results\n   rlang,      # read in excel files\n   forcats,    # read in excel files\n   broom,      # tidy code\n   readxl,     # read in excel files\n   pacman,     # loading and reading in packages\n   rio,        # importing data  \n   here,       # relative file pathways  \n   janitor,    # data cleaning and tables\n   lubridate,  # working with dates\n   matchmaker, # dictionary-based cleaning\n   epikit,     # age_categories() function\n   tidyverse,  # data management and visualization\n   gtsummary,  # logistic regression and plotting results\n   gt,         # for gtsummary \n   flextable,  # table creation and manipulating\n   car,        # data management and visualization\n   readstata13,# read in Stata files\n   finalfit,   # logistic regression and plotting results\n   survminer,  # forest plots\n   easystats, \n   BiocManager, \n   survival, \n   forestplot, \n   rticles,     # templates for scientific journal articles in RMarkdown\n   jtools, \n   corrplot, \n   codebookr,\n   codebook,\n   sjlabelled, \n   likert, \n   kableExtra, \n   haven,\n   here,\n   flexdashboard, # dashboard versions of R Markdown reports\n   plotly, # interactive plots\n   shiny, \n   webshot, \n   webshot2, \n   grateful,\n   sf,\n   cowplot,\n   tmap,\n   mapview,\n   RColorBrewer\n   )\n```\n:::\n\n\n### Study design and participants {#sec-study-design}\n\nEnhancing Treatment of Hepatitis C in Opioid Substitution Settings\n(ETHOS) Engage is a national observational cohort study of people who\nhave a history of injecting drug use, and report injecting drug use in\nthe preceding six months or are currently receiving OAT (either\nmethadone, buprenorphine, buprenorphine-naloxone or long-acting\ninjectable buprenorphine in Australia). The study procedures have been\ndescribed in detail elsewhere (Valerio et al., 2020). Participants were\nenrolled across two recruitment waves. During Wave 1 (May 2018-\nSeptember 2019) recruitment occurred in 25 sites, including drug\ntreatment clinics (n = 21) and needle and syringe programs (NSPs) (n =\n4). Following Wave I, the study protocol and questionnaire was ammended\nto include questions around preferences for opioid agonist therapy and\nassociated factors. Following this, only participants receruited in Wave\nII are included in this analyses and individuals who were enrolled\nwithin and between Wave 1 and Wave 2 were identified by two-by-two name\ncode (first two letters of first name and last name) and date of birth\nincluded. During Wave 2 (November 2019-June 2021), participants were\nrecruited from 21 of the 25 sites which participated in Wave 1,\nincluding drug treatment clinics (n = 19) and NSPs (n = 2) in New South\nWales ( n = 17), Queensland (n = 4), South Australia (n = 2) and Western\nAustralia ( n = 2) (@fig-map). The content within this article is\npresented following the 'Strengthening the reporting of observational\nstudies in epidemiology'(STROBE) guidelines [@von2007;\n@Vandenbroucke2007]. A completed checklist of the STROBE requirements is\navailable in the @sec-supp-material.\n\nInclusion criteria were informed consent, age \\>18 years, and injecting\ndrug use, either within the previous six months or lifetime history and\ncurrent OAT. Due to contraindications with Fibroscan®, people who were\npregnant were excluded from Wave The study protocol was amended for Wave\n2 to include pregnant participants (FibroScan® was withheld for those\nindividuals). The first enrolment was used for all participants who\nparticipated more than once within each recruitment wave. The initial\nstudy protocol and amendments were approved by the Human Research Ethics\nCommittees at St Vincent's Hospital, Sydney (HREC Ref: HREC/17/SVH/113)\nand the Aboriginal Health and Medical Research Council (HREC Ref:\n1279/17).\n\n### Procedures {#sec-procedures}\n\nETHOS Engage was advertised preceding recruitment with posters, cards\ndistributed with sterile injecting equipment from NSPs and by word of\nmouth, but service staff were not directly involved in recruitment.\nRecruitment spanned one to five days per site and included a team of\npeers, university staff, and clinic personnel. Campaign days were run in\nmultiple stages. First, participants provided 100μl finger-stick\ncapillary whole-blood to test for HCV RNA using the point-of-care Xpert\nHCV Viral Load Fingerstick Assay (Cepheid, Sunnyvale, United States;\nlower limit of quantification 100IU/ml, upper limit of quantification\nlog10 IU/ml; 100% sensitivity, 100% specificity) (Lamoury et al.\n2018).Procedures are described in detail in Valerio (2021). Participants\nthen self-completed a computer tablet-based questionnaire collecting\ndemographics, behavioural risk, and HCV history, OAT preferences, drug\nuse characteristics and drug treatment history. All participants were\nreimbursed (AUD\\$30 voucher) for their time and out-of-pocket expenses.\n\n\n::: {.cell .hidden layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\nload(\n  here::here(\"data_processed\", \"ethos_working.rda\"))\n\nload(\n  here::here(\"data_processed\", \"ethos_factors.rda\"))\n\nshape <- read_sf(dsn = \"C:/Users/mjstowe/OneDrive - UNSW/Desktop/R\", layer = \"Primary_Health_Networks\")\n\nethos.loc <- read.csv(\"~/GitHub/ethos/raw_data/ethos_locations.csv\")\n```\n:::\n\n::: {.cell layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n# Static map of ETHOS locations in Australia\n\n#| label: fig-map\n\nmap <- ggplot() + \n  geom_sf(data = shape) +\n   xlim(105, 160) +\n  # geom_rect(aes(xmin = 148, xmax = 154, ymin = -36, ymax = -26), color = \"red\", fill =   NA) +\n  labs() +\nlabs( x=\"\",\n      y=\"\") +\n  theme_test() +\n  theme(panel.background = element_rect(fill = \"lightblue\")) +\n    geom_point(aes(x = Longitude,\n                 y = Latitude, fill = \"red\"), shape= 21, colour=\"black\", data = ethos.loc, size=2, show.legend = FALSE) \n\nmap\n```\n\n::: {.cell-output-display}\n![](index_files/figure-html/unnamed-chunk-4-1.png){fig-align='center' width=672}\n:::\n:::\n\n::: {.cell .hidden layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\nethos.loc <- read.csv(\"~/GitHub/ethos/raw_data/ethos_locations.csv\") %>%\n  st_as_sf(coords = c(\"Longitude\", \"Latitude\"), remove = FALSE)\n\nmy.pal2 = brewer.pal(n=7, \"GnBu\")\n```\n:::\n\n::: {.cell layout-align=\"center\" fgb='false'}\n\n```{.r .cell-code .hidden}\n# Interactive map of ETHOS locations across Australia \n\n# mapview(shape, alpha.regions = 0, colour = \"red\", lwd = 2, layer.name = \"Primary Health Networks, Australia\")  +\n# mapview(ethos.loc, zcol=\"rna_prev\", layer.name = \"HCV RNA prevalence (%)\", col.regions = my.pal2) +\n# mapview(ethos.loc, zcol=\"recruitment\", layer.name = \"No. of participants recruited\")\n```\n:::\n\n\n### Outcomes {#sec-outcomes}\n\nThe primary outcome was a preference for opioid agonist therapy, which\nwas assessed by asking the question \"*Of all the following types of\nmedications used for opioid agonist therapy, if you could choose today,\nwhich one would you prefer?*\" Options included methadone,\nmonobuprenorphine (Subutex), buprenorphine-naloxone (Suboxone) taken\norally as a film or tablet, long acting injectable buprenorphine\n(Buvidal or Sublocade), any treatment (i.e. no preference for any\nmedication), and no treatment.\n\nFrequencies and percentages were generated from responses. Demographic,\nbehavioural, and clinical factors hypothesised to be associated with\npreference to receive OAT treatment were determined were determined\nthrough consultation with people who use drugs and previous research\nthat looked into factors associated with OAT preferences (e.g. Stowe et\nal. 2023 in press; Larance et al. 2020; Rolland et al. 2019; 2021priori,\ncomprising the following: 1) age at survey (18 - 29; 30 -- 39; 40 -- 49;\n\\> 50 years old) ), 2) gender (female; male; transgender), 3) education\n(\\< year 10; \\> year 10), 4) employment (formal; informal), 5)\nhomelessness (yes; no), 6) incarceration history (never, \\>1 year ago,\nwithin the last year), 7) recency and frequency of injection drug use\n(\\>1 year ago, within 1--12 months ago, within the last month less than\ndaily, and daily or more), 8) drugs injected in the last month (none,\nheroin, other opioids, methamphetamine, other), 9) previous OAT (yes;\nno), 10) previous OAT with methadone (yes; no); and 11) previous OAT\nwith buprenorphine (yes; no). Among those currently receiving OAT,\nfactors included 1) current OAT medication (methadone; buprenorphine;\nbuprenorphine-naloxone; long acting depot buprenorphine; none) and\ncurrent dosages (mg).\n\n6 The exposure of interest was recruitment Wave (Wave 1, May 2018 --\nSeptember 2019; Wave 7 2, November 2019 -- June 2021). Other demographic\nand behavioural factors hypothesised to 8 be associated with current HCV\ninfection and HCV treatment were determined using 9 previously published\nETHOS Engage Wave 1 results (Valerio et al. 2021c) and included: (i) 10\nage at survey (stratified around median), (ii) gender (male, female,\nother \\[non11 binary/transgender/other\\]), (iii) Aboriginal or Torres\nStrait Islander, (iv) homelessness, (v) 12 OAT status (never, past,\nwithin the last month/current), (vi) incarceration history (never, 13\nhistory only \\[not recent\\], recent \\[previous 12 months in Wave 1 and\nprevious six months in 14 Wave 2\\]), (vii) recency and frequency of\ninjecting drug use (\\>1 year ago, within the previous 15 1-12 months,\nwithin the previous month \\<daily, and \\>daily). In analyses among those\nwith 16 injecting drug use in the previous month, injecting-related\nexposure variables were recoded as 17 recency of injecting (\\<daily,\n\\>daily) and main drug injected in the last month was assessed 18\n(heroin, other opioids, methamphetamine, other).\n\n### Statistical analysis {#sec-analysis}\n\nThe proportion of people who reported preference for methadone and\nfactors associated with this preference was assessed. Quantitative\nparameters are presented as the median and interquartile range \\[IQR\\].\nCategorical parameters are presented as the number and percentage (n;\n%). The association between the response to each variable and the\nbinarized category of preference for methadone was explored using\nlogistic regression modeling through unadjusted bivariate analysis,\nproviding an odds ratio and the 95 % confidence interval (OR \\[95%\nCI\\]), and comparisons adjusted for age category and gender, providing\nan adjusted OR (aOR) and the 95 % CI. A sample of those who would choose\ntreatment and who had a preference for methadone or any buprenorphine\nforumation was selected for analysis (n=352) . Multivariable logistic\nregression was used assess factors associated with preferred medication\nfor OAT. Unadjusted and adjusted odds ratios were derived using logistic\nregression and 95% confidence intervals calculated for all variables.\nFor the final model, all the explanatory variables significantly\nassociated with the outcome in the bivariate models were included in the\nmultivariable model, whilst also adjusting for age and gender. The final\nmodel was assessed through examining which contributed significantly to\nmodel fit through backwards selection using decreasing values of Akaike\nInformation Criterion. The variance inflation factor was used to assess\ncollinearity in the final model [@obrien2007]. Individuals with missing\nvalues were not integrated in the models. A subset of the sample\ncomprising of participants currently receiving OAT with methadone and\nbuprenorphine (including sublingual-monobuprenorphine,\nbuprenorphine-naloxone and long-acting injectable buprenorphine) was\nselected for analysis. There was no formal sample size calculation,\nhowever, based of similar previous surveys (e.g. [@larance2020;\n@rolland2021]) we aimed to recruit 300 - 400 people.\n\nThe analytical approach received input from and was reviewed by people\nwho use drugs, with lived- and living-experience of injecting drug use\nand opioid agonist therapy with various formulations of methadone and\nbuprenorphine. Advice and perspectives were provided on the inclusion of\nexplanatory variables and the clinical and practical significance of\nidentified factors.\n\nThe analysis was undertaken in using `R` version @stats using the\nfollowing packages: gtsummary v. 1.7.2 [@gtsummary], quarto v. 1.3\n[@quarto]. The code for this analysis is available on request from the\ncorresponding author. The data supporting the findings of this study are\navailable within the article and its Supporting information. The\nanalysis was not pre-registered and the results should be considered\nexploratory.\n\n### Study oversight {#sec-oversight}\n\nAll participants provided written informed consent before study\nprocedures. The study protocol were approved by the Human Research\nEthics Committees at St Vincent's Hospital, Sydney (HREC Ref:\nHREC/17/SVH/113) and the Aboriginal Health and Medical Research Council\n(HREC Ref: 1279/17). This study was conducted according to the\nDeclaration of Helsinki and International Conference on Harmonization\nGood Clinical Practice (ICH/GCP) guidelines.\n\n### Role of the Funding source {#sec-funding}\n\nThe study was funded by a research grant from X. The funders had no role\nin the study design, data collection, analysis, interpretation of the\nresults, writing or the decision to submit the study for publication.\nJG, AC, LD, and MJS had access to the raw data. The National Drug and\nAlcohol Research Centre and the Kirby Institute, UNSW Sydney\ncollaborated to design the study, monitor study conduct, and perform the\nstatistical analysis. X, X and X were responsible for the decision to\nsubmit the study for publication.\n\n## Results {#sec-results}\n\n\n::: {.cell .hidden layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n# p <- p %>%\n# mutate(prefer.factor = fct_relevel(prefer.factor,\"Methadone\", \"Buprenorphine\"))\n```\n:::\n\n\n### Participant Characteristics {#sec-participants}\n\nOverall, XXX participants were enrolled (@fig-profile). The median age\nwas XX years, XX% (n=XXX) were female, XX% (n=XX) incarcerated in the\nlast six months and XX% (n=XX) were currently living with chronic pain\n(@tbl-participants).\n\nAt enrollment, XX% (n=XX) had injected drugs in the month prior, with\n45% (n=141 of 310) having injected drugs \\>daily. Most participants were\ntreatment experienced (n = 344; 87%), with 91% (n=X) with most having\nreceived methadone (n = 319; 91%) compared to buprenorphine (n = 344;\n87%) (@tbl-s1). Among those who injected, commonly injected drugs in the\nprior month included heroin (90%), non-prescribed methadone (13%%),\nnon-prescribed buprenorphine (10%), other non-prescribed pharmaceutical\nopioids (X%), methamphetamine (X%), cocaine (X%) and benzodiazepines\n(X%)\n\nOf the participants currently receiving OAT, XX% (n=XX) were prescribed\nmethadone, XX% (n=XX) buprenorphine-naloxone (Suboxone), XX% (n=XX)\nlong-acting injectable buprenorphine (Buivdal or Sublocade) 3% (n=9),\nbuprenorphine (Subutex) and X% (n=X) were not in treatment. Among those\nreceving treatment, most collected their last dose at pharmacies XX%\n(n=XX) or public clinics (n=111; 35%), with just over half (n=177; 56%)\ntravelling less than five kilometers (@tbl-s2).\n\n\n::: {.cell layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n#| label: tbl-participants\n\ntbl_characteristics <- ethos_yn %>% \n  filter(waves==\"Wave 2\")%>%\n  filter(prefer.treat.yn == \"Yes\"| prefer.treat.yn== \"No\")%>%\n  gtsummary::tbl_summary(\n    include = c(surveyage,age_44, genderall.factor,  homeless.fct,\n                     prison.yn, inject.month,\n                     inject.year, injectdrug_group.month, \n                injectdrug.month,\n                     injectfreq.month.daily, injectdays.month,\n                     oat_current.yn, \n                     oat_duration_01,\n                     oat.ever.yn,  \n                     oat.type,\n                     methadone.dose,\n                     laib.dose.wk, \n                     laib.dose.month,\n                     dose.satisfied,\n                oat.prefer,\n                prefer.treat.yn,\n                health.pain,\n                     dose.location, \n                     dose.takeaways.yn,\n                     stigma.inject.yn,\n                \n                     discrim.yn, \n                methadonebupe_pref, \n                med_pref),\n                   label = list(\n                            surveyage ~ \"Age\"),\n                           # edu.factor ~ \"Formal education\",\n                           # gender.mf ~ \"Gender\",\n                           # prison.yn ~ \"Ever incarcerated\", \n                           # homeless.fct ~ \"Currently homeless\"\n                           # income.yn ~ \"Currently employed\",\n                           # chronicpain.yn ~ \"Chronic pain\",\n                           \n    statistic = list(all_categorical() ~ \"{n} ({p}%)\"), \n    missing=\"no\"\n  ) %>%\n  gtsummary::bold_labels() %>%   \n  gtsummary::modify_header(\n    label = \"**Characteristic**\", \n    all_stat_cols() ~ \"**{level}**\\nN = {n}\"\n  )\n\ntbl_characteristics.kable <- tbl_characteristics %>% \n   gtsummary::as_kable_extra(\n    format = \"html\",\n    booktabs = TRUE,\n    longtable = TRUE,\n    linesep = \"\",\n    caption=\"Table 1. Demographic and behavioural characteristics of all participants enrolled in this study\")%>%\n  kableExtra::kable_styling(\n      position = \"left\",\n      latex_options = c(\"striped\", \"repeat_header\"),\n      stripe_color = \"gray!15\"\n    )\n\ntbl_characteristics\n```\n\n::: {.cell-output-display}\n\n```{=html}\n<div id=\"btjokczccq\" style=\"padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;\">\n<style>#btjokczccq table {\n  font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\n  -webkit-font-smoothing: antialiased;\n  -moz-osx-font-smoothing: grayscale;\n}\n\n#btjokczccq thead, #btjokczccq tbody, #btjokczccq tfoot, #btjokczccq tr, #btjokczccq td, #btjokczccq th {\n  border-style: none;\n}\n\n#btjokczccq p {\n  margin: 0;\n  padding: 0;\n}\n\n#btjokczccq .gt_table {\n  display: table;\n  border-collapse: collapse;\n  line-height: normal;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 16px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: auto;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#btjokczccq .gt_caption {\n  padding-top: 4px;\n  padding-bottom: 4px;\n}\n\n#btjokczccq .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#btjokczccq .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 3px;\n  padding-bottom: 5px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#btjokczccq .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#btjokczccq .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#btjokczccq .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#btjokczccq .gt_col_heading {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#btjokczccq .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#btjokczccq .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#btjokczccq .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#btjokczccq .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 5px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#btjokczccq .gt_spanner_row {\n  border-bottom-style: hidden;\n}\n\n#btjokczccq .gt_group_heading {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  text-align: left;\n}\n\n#btjokczccq .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#btjokczccq .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#btjokczccq .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#btjokczccq .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#btjokczccq .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#btjokczccq .gt_stub_row_group {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 5px;\n  padding-right: 5px;\n  vertical-align: top;\n}\n\n#btjokczccq .gt_row_group_first td {\n  border-top-width: 2px;\n}\n\n#btjokczccq .gt_row_group_first th {\n  border-top-width: 2px;\n}\n\n#btjokczccq .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#btjokczccq .gt_first_summary_row {\n  border-top-style: solid;\n  border-top-color: #D3D3D3;\n}\n\n#btjokczccq .gt_first_summary_row.thick {\n  border-top-width: 2px;\n}\n\n#btjokczccq .gt_last_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#btjokczccq .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#btjokczccq .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#btjokczccq .gt_last_grand_summary_row_top {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-style: double;\n  border-bottom-width: 6px;\n  border-bottom-color: #D3D3D3;\n}\n\n#btjokczccq .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#btjokczccq .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#btjokczccq .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#btjokczccq .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#btjokczccq .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#btjokczccq .gt_sourcenote {\n  font-size: 90%;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#btjokczccq .gt_left {\n  text-align: left;\n}\n\n#btjokczccq .gt_center {\n  text-align: center;\n}\n\n#btjokczccq .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#btjokczccq .gt_font_normal {\n  font-weight: normal;\n}\n\n#btjokczccq .gt_font_bold {\n  font-weight: bold;\n}\n\n#btjokczccq .gt_font_italic {\n  font-style: italic;\n}\n\n#btjokczccq .gt_super {\n  font-size: 65%;\n}\n\n#btjokczccq .gt_footnote_marks {\n  font-size: 75%;\n  vertical-align: 0.4em;\n  position: initial;\n}\n\n#btjokczccq .gt_asterisk {\n  font-size: 100%;\n  vertical-align: 0;\n}\n\n#btjokczccq .gt_indent_1 {\n  text-indent: 5px;\n}\n\n#btjokczccq .gt_indent_2 {\n  text-indent: 10px;\n}\n\n#btjokczccq .gt_indent_3 {\n  text-indent: 15px;\n}\n\n#btjokczccq .gt_indent_4 {\n  text-indent: 20px;\n}\n\n#btjokczccq .gt_indent_5 {\n  text-indent: 25px;\n}\n</style>\n<table class=\"gt_table\" data-quarto-disable-processing=\"false\" data-quarto-bootstrap=\"false\">\n  <thead>\n    \n    <tr class=\"gt_col_headings\">\n      <th class=\"gt_col_heading gt_columns_bottom_border gt_left\" rowspan=\"1\" colspan=\"1\" scope=\"col\" id=\"&lt;strong&gt;Characteristic&lt;/strong&gt;\"><strong>Characteristic</strong></th>\n      <th class=\"gt_col_heading gt_columns_bottom_border gt_center\" rowspan=\"1\" colspan=\"1\" scope=\"col\" id=\"&lt;strong&gt;Overall&lt;/strong&gt;&#10;N = 726&lt;span class=&quot;gt_footnote_marks&quot; style=&quot;white-space:nowrap;font-style:italic;font-weight:normal;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;\"><strong>Overall</strong>\nN = 726<span class=\"gt_footnote_marks\" style=\"white-space:nowrap;font-style:italic;font-weight:normal;\"><sup>1</sup></span></th>\n    </tr>\n  </thead>\n  <tbody class=\"gt_table_body\">\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Age</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">45 (39, 52)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">age_44</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">350 (48%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Gender</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Male</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">481 (66%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Female</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">233 (32%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Transgender</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">12 (1.7%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Homeless</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">62 (8.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Ever incarcerated</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">478 (66%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Recent injecting (prior month)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">469 (65%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Recent injecting (prior year)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">44 (24%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Drug group injected (prior month)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Opioids</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">228 (49%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Stimulants</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">233 (50%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Benzodiazepines</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">1 (0.2%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Other</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">7 (1.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Drugs injected (prior month)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Heroin</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">173 (37%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Other opioids</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">55 (12%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Amphetamines</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">228 (49%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Cocaine</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">5 (1.1%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Benzodiazepines</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">1 (0.2%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Other</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">7 (1.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Drug injection frequency</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Less than daily or daily</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">204 (43%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    More than daily</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">265 (57%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">injectdays.month</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">8 (3, 20)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Currently on OAT</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">440 (85%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Current OAT duration period</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Less than 3 months</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">0 (NA%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    3 months-2 years</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">0 (NA%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    More than 2 years</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">0 (NA%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Ever received OAT</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">518 (71%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Current OAT medication</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Methadone</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">253 (58%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine (Subutex)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">58 (13%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine (Any formulation)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">9 (2.0%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine (long acting injectable)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">49 (11%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine-naloxone (Suboxone)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">59 (13%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Other</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">4 (0.9%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Unknown</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">8 (1.8%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">methadone.dose</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">75 (44, 100)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">laib.dose.wk</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    16</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">2 (22%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    24</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">4 (44%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    32</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">3 (33%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">laib.dose.month</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    64</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">9 (29%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    92</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">2 (6.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    96</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">5 (16%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    100</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">2 (6.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    126</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">1 (3.2%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    128</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">10 (32%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    160</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">1 (3.2%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    300</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">1 (3.2%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Dose satisfaction</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Yes</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">358 (81%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    No, too low</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">65 (15%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    No, too high</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">17 (3.9%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">OAT preference</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Methadone</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">303 (42%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine (Subutex)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">104 (14%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine (Any formulation)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">21 (2.9%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine (long acting injectable)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">82 (11%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine-naloxone (Suboxone)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">40 (5.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Any - no preference</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">33 (4.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    None - no medication or treatment</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">26 (3.6%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    None - no appropriate medication</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">38 (5.2%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    None - not interested in treatment</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">79 (11%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Treatment preference</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">583 (80%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Current physical health</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    I have no pain or discomfort</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">290 (40%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    I have slight pain or discomfort</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">184 (25%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    I have moderate pain or discomfort</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">127 (17%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    I have severe pain or discomfort</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">93 (13%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    I have extreme pain or discomfort</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">32 (4.4%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Location last dose dispensed</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Pharmacy</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">55 (13%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Public</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">321 (73%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Private</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">43 (9.8%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Doctor</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">5 (1.1%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Prison</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">2 (0.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Other</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">14 (3.2%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Receives takeway doses</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">148 (34%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Ever experienced injecting stigma</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">426 (59%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Ever experienced discrimination</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">338 (47%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Medication preference</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Methadone</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">303 (42%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">247 (34%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Any</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">33 (4.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    None</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">143 (20%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\" style=\"font-weight: bold;\">Medication preference</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\"><br /></td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Methadone</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">303 (42%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine (oral)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">144 (20%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine (oral - any formulation)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">21 (2.9%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Buprenorphine (LAIB)</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">82 (11%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    Any</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">33 (4.5%)</td></tr>\n    <tr><td headers=\"label\" class=\"gt_row gt_left\">    None</td>\n<td headers=\"stat_0\" class=\"gt_row gt_center\">143 (20%)</td></tr>\n  </tbody>\n  \n  <tfoot class=\"gt_footnotes\">\n    <tr>\n      <td class=\"gt_footnote\" colspan=\"2\"><span class=\"gt_footnote_marks\" style=\"white-space:nowrap;font-style:italic;font-weight:normal;\"><sup>1</sup></span> Median (IQR); n (%)</td>\n    </tr>\n  </tfoot>\n</table>\n</div>\n```\n\n:::\n\n```{.r .cell-code .hidden}\ntbl_characteristics.kable\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table style=\"NAborder-bottom: 0; \" class=\"table\">\n<caption>Table 1. Demographic and behavioural characteristics of all participants enrolled in this study</caption>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\"> Characteristic </th>\n   <th style=\"text-align:center;\"> Overall<br>N = 726 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Age</span> </td>\n   <td style=\"text-align:center;\"> 45 (39, 52) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">age_44</span> </td>\n   <td style=\"text-align:center;\"> 350 (48%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Gender</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Male </td>\n   <td style=\"text-align:center;\"> 481 (66%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Female </td>\n   <td style=\"text-align:center;\"> 233 (32%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Transgender </td>\n   <td style=\"text-align:center;\"> 12 (1.7%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Homeless</span> </td>\n   <td style=\"text-align:center;\"> 62 (8.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Ever incarcerated</span> </td>\n   <td style=\"text-align:center;\"> 478 (66%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Recent injecting (prior month)</span> </td>\n   <td style=\"text-align:center;\"> 469 (65%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Recent injecting (prior year)</span> </td>\n   <td style=\"text-align:center;\"> 44 (24%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Drug group injected (prior month)</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Opioids </td>\n   <td style=\"text-align:center;\"> 228 (49%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Stimulants </td>\n   <td style=\"text-align:center;\"> 233 (50%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Benzodiazepines </td>\n   <td style=\"text-align:center;\"> 1 (0.2%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Other </td>\n   <td style=\"text-align:center;\"> 7 (1.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Drugs injected (prior month)</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Heroin </td>\n   <td style=\"text-align:center;\"> 173 (37%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Other opioids </td>\n   <td style=\"text-align:center;\"> 55 (12%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Amphetamines </td>\n   <td style=\"text-align:center;\"> 228 (49%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Cocaine </td>\n   <td style=\"text-align:center;\"> 5 (1.1%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Benzodiazepines </td>\n   <td style=\"text-align:center;\"> 1 (0.2%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Other </td>\n   <td style=\"text-align:center;\"> 7 (1.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Drug injection frequency</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Less than daily or daily </td>\n   <td style=\"text-align:center;\"> 204 (43%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> More than daily </td>\n   <td style=\"text-align:center;\"> 265 (57%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">injectdays.month</span> </td>\n   <td style=\"text-align:center;\"> 8 (3, 20) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Currently on OAT</span> </td>\n   <td style=\"text-align:center;\"> 440 (85%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Current OAT duration period</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Less than 3 months </td>\n   <td style=\"text-align:center;\"> 0 (NA%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 3 months-2 years </td>\n   <td style=\"text-align:center;\"> 0 (NA%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> More than 2 years </td>\n   <td style=\"text-align:center;\"> 0 (NA%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Ever received OAT</span> </td>\n   <td style=\"text-align:center;\"> 518 (71%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Current OAT medication</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Methadone </td>\n   <td style=\"text-align:center;\"> 253 (58%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine (Subutex) </td>\n   <td style=\"text-align:center;\"> 58 (13%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine (Any formulation) </td>\n   <td style=\"text-align:center;\"> 9 (2.0%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine (long acting injectable) </td>\n   <td style=\"text-align:center;\"> 49 (11%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine-naloxone (Suboxone) </td>\n   <td style=\"text-align:center;\"> 59 (13%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Other </td>\n   <td style=\"text-align:center;\"> 4 (0.9%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Unknown </td>\n   <td style=\"text-align:center;\"> 8 (1.8%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">methadone.dose</span> </td>\n   <td style=\"text-align:center;\"> 75 (44, 100) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">laib.dose.wk</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 16 </td>\n   <td style=\"text-align:center;\"> 2 (22%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 24 </td>\n   <td style=\"text-align:center;\"> 4 (44%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 32 </td>\n   <td style=\"text-align:center;\"> 3 (33%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">laib.dose.month</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 64 </td>\n   <td style=\"text-align:center;\"> 9 (29%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 92 </td>\n   <td style=\"text-align:center;\"> 2 (6.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 96 </td>\n   <td style=\"text-align:center;\"> 5 (16%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 100 </td>\n   <td style=\"text-align:center;\"> 2 (6.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 126 </td>\n   <td style=\"text-align:center;\"> 1 (3.2%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 128 </td>\n   <td style=\"text-align:center;\"> 10 (32%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 160 </td>\n   <td style=\"text-align:center;\"> 1 (3.2%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> 300 </td>\n   <td style=\"text-align:center;\"> 1 (3.2%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Dose satisfaction</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Yes </td>\n   <td style=\"text-align:center;\"> 358 (81%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> No, too low </td>\n   <td style=\"text-align:center;\"> 65 (15%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> No, too high </td>\n   <td style=\"text-align:center;\"> 17 (3.9%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">OAT preference</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Methadone </td>\n   <td style=\"text-align:center;\"> 303 (42%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine (Subutex) </td>\n   <td style=\"text-align:center;\"> 104 (14%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine (Any formulation) </td>\n   <td style=\"text-align:center;\"> 21 (2.9%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine (long acting injectable) </td>\n   <td style=\"text-align:center;\"> 82 (11%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine-naloxone (Suboxone) </td>\n   <td style=\"text-align:center;\"> 40 (5.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Any - no preference </td>\n   <td style=\"text-align:center;\"> 33 (4.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> None - no medication or treatment </td>\n   <td style=\"text-align:center;\"> 26 (3.6%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> None - no appropriate medication </td>\n   <td style=\"text-align:center;\"> 38 (5.2%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> None - not interested in treatment </td>\n   <td style=\"text-align:center;\"> 79 (11%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Treatment preference</span> </td>\n   <td style=\"text-align:center;\"> 583 (80%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Current physical health</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> I have no pain or discomfort </td>\n   <td style=\"text-align:center;\"> 290 (40%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> I have slight pain or discomfort </td>\n   <td style=\"text-align:center;\"> 184 (25%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> I have moderate pain or discomfort </td>\n   <td style=\"text-align:center;\"> 127 (17%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> I have severe pain or discomfort </td>\n   <td style=\"text-align:center;\"> 93 (13%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> I have extreme pain or discomfort </td>\n   <td style=\"text-align:center;\"> 32 (4.4%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Location last dose dispensed</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Pharmacy </td>\n   <td style=\"text-align:center;\"> 55 (13%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Public </td>\n   <td style=\"text-align:center;\"> 321 (73%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Private </td>\n   <td style=\"text-align:center;\"> 43 (9.8%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Doctor </td>\n   <td style=\"text-align:center;\"> 5 (1.1%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Prison </td>\n   <td style=\"text-align:center;\"> 2 (0.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Other </td>\n   <td style=\"text-align:center;\"> 14 (3.2%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Receives takeway doses</span> </td>\n   <td style=\"text-align:center;\"> 148 (34%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Ever experienced injecting stigma</span> </td>\n   <td style=\"text-align:center;\"> 426 (59%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Ever experienced discrimination</span> </td>\n   <td style=\"text-align:center;\"> 338 (47%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Medication preference</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Methadone </td>\n   <td style=\"text-align:center;\"> 303 (42%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine </td>\n   <td style=\"text-align:center;\"> 247 (34%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Any </td>\n   <td style=\"text-align:center;\"> 33 (4.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> None </td>\n   <td style=\"text-align:center;\"> 143 (20%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> <span style=\" font-weight: bold;    \">Medication preference</span> </td>\n   <td style=\"text-align:center;\">  </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Methadone </td>\n   <td style=\"text-align:center;\"> 303 (42%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine (oral) </td>\n   <td style=\"text-align:center;\"> 144 (20%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine (oral - any formulation) </td>\n   <td style=\"text-align:center;\"> 21 (2.9%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Buprenorphine (LAIB) </td>\n   <td style=\"text-align:center;\"> 82 (11%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> Any </td>\n   <td style=\"text-align:center;\"> 33 (4.5%) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;padding-left: 2em;\" indentlevel=\"1\"> None </td>\n   <td style=\"text-align:center;\"> 143 (20%) </td>\n  </tr>\n</tbody>\n<tfoot><tr><td style=\"padding: 0; \" colspan=\"100%\">\n<sup>1</sup> Median (IQR); n (%)</td></tr></tfoot>\n</table>\n\n`````\n:::\n:::\n\n\n### Preferences for OAT {#sec-preferences}\n\nAmong all participants (n=X), X% (n=xx) would prefer to receive OAT,\nwith XX% (n=XX) preferring either methadone or any formulation of\nbuprenorphine and XX% (n=XX) choosing treatment, but having no preferred\nmedication. Methadone was preferred by XX% (n=XX) and buprenorphine by\nXX% (n=XX).Among those who preferred buprenorphine, sublingual\nbuprenorphine-naloxone was preferred by XX% (n=XX) and long-acting\ninjectable buprenorphine by XX% (n=XX). A summary of sociodemographic\ncharacteristics stratified by preference is presented in @tbl-s1. Among\nparticipants currently receiving XX% (n=XX), XX% (n=XX) preferred either\noral methadone or any formulation of buprenorphine, XX% (n=XX) would\nchoose treatment, but had no preferred medications and XX% (n=XX) would\nprefer not to receive treatment. Methadone was preferred by 60% XX%\n(n=XX), oral and sublingual by XX% (n=XX) and long-acting injectable\nbuprenorphine by XX% (n=XX). A summary of sociodemographic\ncharacteristics of people currently receiving OAT stratified by\npreference is presented in @tbl-s2.\n\n![Study profile](figures/profile.png){#fig-profile}\n\n\n::: {.cell .hidden layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n# p <- p %>%\n#   mutate(prefer.factor = fct_relevel(prefer.factor, \"Methadone\", \"Buprenorphine\"))\n\n# stratified.model <-  \n#   ethos_ny %>% \n#   tbl_summary(by = prefer.factor, \n#               include = c(age, age_group, \n#                           gender.mf, edu.factor,\n#                           income.factor.yn, homeless.factor.yn,         \n#                           prison.factor, chronicpain.factor.yn,\n#                           heroin.month.factor,  \n#                           nonmethadone.month.factor,\n#                           nonbupe.month.factor, \n#                           cocaine.month.factor, meth.month.factor, \n#                           benzo.month.factor,otheropi.month.factor,\n#                           oat.yn.f, methadoneever.yn, bupeever.factor\n#               ),\n#               label = c(age ~ \"Age\",\n#                         agegroup ~ \"Age group\",\n#                         gender.mf ~ \"Gender\",\n#                         homeless.factor.yn ~ \"Currently in stale housing\",\n#                         otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n#                         methadoneever.yn ~ \"Ever received OAT with methadone\",\n#                            bupeever.factor ~ \"Ever received OAT with buprenorphine\"\n#                           ),\n#               type = all_categorical()~\"categorical\",\n#               missing = \"no\",\n#               percent = \"row\",\n#               statistic = all_continuous() ~ (\"{median} ({p25} - {p75})\")) %>%\n#   add_stat_label()%>%\n#   add_overall(statistic = list(all_continuous()  ~ \"{median} ({p25} - {p75})\",\n#                                all_categorical() ~ \"{n}\")) %>% \n#   modify_footnote(update = everything() ~ NA, abbreviation = FALSE) %>%\n#   modify_header(\n#     stat_0 = '**Enrolled** \\n **(n = {n})**',\n#     stat_1 = '**Methadone** \\n **(n = {n})**',\n#     stat_2 = '**Buprenorphine** \\n **(n = {n})**'\n#   ) %>% \n#   bold_labels()\n#  \n# \n# stratified.model.kable <- stratified.model %>% \n#    gtsummary::as_kable_extra(\n#     format = \"html\",\n#     booktabs = TRUE,\n#     longtable = TRUE,\n#     linesep = \"\",\n#     caption=\"Demographic and behavioural characteristics of all participants stratified by preference for methadone or buprenorphine (n=352)\")%>%\n#   kableExtra::kable_styling(\n#       position = \"left\",\n#       latex_options = c(\"striped\", \"repeat_header\"),\n#       stripe_color = \"gray!15\"\n#     )\n# \n# stratified.model.kable\n```\n:::\n\n::: {.cell .hidden layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n# p <- p %>%\n# mutate(prefer.factor = fct_relevel(prefer.factor, \"Buprenorphine\", \"Methadone\"))\n```\n:::\n\n::: {.cell .hidden layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n# subset_cor <-\n#   p %>%\n#   dplyr::select(age, gender.mf,edu.factor, income.factor.yn, homeless.factor.yn,  \n#                 prison.factor, chronicpain.factor.yn, heroin.month.factor, \n#                 nonmethadone.month.factor,\n#                 nonbupe.month.factor, otheropi.month.factor, \n#                 cocaine.month.factor, meth.month.factor, benzo.month.factor, oat.yn.f, methadoneever.yn, bupeever.factor, prefer.factor) %>%\n#   tbl_uvregression(\n#     method = glm,\n#     y = prefer.factor, \n#     label = list(age ~ \"Age\",\n#                  gender.mf ~ \"Gender\",\n#                  otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n#                  homeless.factor.yn ~ \"Currently in stale housing\",\n#                  methadoneever.yn ~ \"Ever received OAT with methadone\",\n#                  bupeever.factor ~ \"Ever received OAT with buprenorphine\"),\n#     method.args = list(family = binomial),\n#     exponentiate = TRUE,\n#     hide_n = TRUE,\n#     pvalue_fun = function(x) style_pvalue(x, digits = 3)\n#   ) %>%\n#   modify_header(\n#     label = '**Variable**',\n#     estimate = '**cOR**',\n#     ci = '**95% CI**',\n#     p.value = '**p-value**'\n#   ) %>%\n#   modify_footnote(update = everything() ~ NA, abbreviation = TRUE) %>%\n#   modify_table_styling(\n#     column = estimate,\n#     rows = !is.na(estimate),\n#     cols_merge_pattern = \"{estimate} ({conf.low} - {conf.high})\"\n#   ) %>%\n#   modify_header(estimate ~ \"**cOR (95% CI)**\") %>%\n#   modify_table_styling(label = '**Enrolled** \\n **(n = {n})**') %>%\n#   modify_column_hide(c(ci)) %>% \n#   bold_labels()\n# \n# subset_cor.kable <- subset_cor %>%\n#    gtsummary::as_kable_extra(\n#     format = \"html\",\n#     booktabs = TRUE,\n#     longtable = TRUE,\n#     linesep = \"\",\n#     caption=\"Results of a univariate logistic regression with crude odds ratios and 95% confidence intervals\")%>%\n#   kableExtra::kable_styling(\n#       position = \"left\",\n#       latex_options = c(\"striped\", \"repeat_header\"),\n#       stripe_color = \"gray!15\"\n#     )\n# \n# subset_cor.kable\n```\n:::\n\n::: {.cell .hidden layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n# subset_mod_final <- glm(prefer.factor ~ age + gender.mf +\n# heroin.month.factor + nonmethadone.month.factor + nonbupe.month.factor +\n# otheropi.month.factor + methadoneever.yn + bupeever.factor, data =\n# p, family = binomial)\n# \n# \n# model.final <- tbl_regression(subset_mod_final, exponentiate = TRUE,  \n#                               label = \n#                                 list(age ~ \"Age\",\n#                                     gender.mf ~ \"Gender\",\n#                                     otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n#                                     \n#                                     methadoneever.yn ~ \"Ever received OAT with methadone\",\n#                   bupeever.factor ~ \"Ever received OAT with buprenorphine\"\n#                   ),\n# pvalue_fun = function(x) style_pvalue(x, digits = 3))%>%\n# # pvalue_fun = ~style_sigfig(., digits = 4)                              )%>%\n#   modify_header(\n#     label = '**Variable**',\n#     estimate = '**aOR**',\n#     ci = '**95% CI**',\n#     p.value = '**p-value**'\n#   ) %>%\n#   modify_footnote(update = everything() ~ NA, abbreviation = TRUE) %>%\n#   modify_table_styling(\n#     column = estimate,\n#     rows = !is.na(estimate),\n#     cols_merge_pattern = \"{estimate} ({conf.low} - {conf.high})\"\n#   ) %>%\n#   modify_header(estimate ~ \"**aOR (95% CI)**\") %>%\n#   modify_column_hide(c(ci)) %>% \n#   bold_labels() %>%\n#   modify_footnote(everything() ~ NA, abbreviation = TRUE)\n# \n# kable.final <- model.final %>% \n#    gtsummary::as_kable_extra(\n#     format = \"html\",\n#     booktabs = TRUE,\n#     longtable = TRUE,\n#     linesep = \"\",\n#     caption=\"Results of a multivariable logistic regression with adjusted odds ratios and 95% confidence intervals\")%>%\n#   kableExtra::kable_styling(\n#       position = \"left\",\n#       latex_options = c(\"striped\", \"repeat_header\"),\n#       stripe_color = \"gray!15\"\n#     )\n# \n# kable.final\n```\n:::\n\n::: {.cell layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n# table_merged <-\n#   tbl_merge(\n#     tbls = list(stratified.model, subset_cor, model.final),\n#     tab_spanner = c(\"** **\", \"**Unadjusted model**\", \"**Adjusted model**\")) %>%\n#   modify_header(label = \"**Variable**\") %>% # update the column header\n#   modify_footnote(everything() ~ NA)\n# \n# table_merged.kable <- table_merged %>%\n#    gtsummary::as_kable_extra(\n#     format = \"html\",\n#     booktabs = TRUE,\n#     longtable = TRUE,\n#     linesep = \"\", \n#     caption=\"Final model including crude odds ratios (cOR) and adjusted odds ratios (aOR)\")%>%\n#   kableExtra::kable_styling(\n#       position = \"left\",\n#       latex_options = c(\"striped\", \"repeat_header\"),\n#       stripe_color = \"gray!15\"\n#     )\n#     scroll_box(\n#   height = \"50%\",\n#   # width = \"100%\",\n#   box_css = \"border: 1px solid #ddd; padding: 5px; \",\n#   extra_css = NULL,\n#   fixed_thead = TRUE\n# )\n\n# table_merged.kable\n```\n:::\n\n::: {.cell .hidden layout-align=\"center\"}\n\n```{.r .cell-code .hidden}\n# table_merged.kable\n```\n:::\n\n\n### Factors associated with OAT preference {#sec-factors}\n\nOverall, participants who preferred methadone were more likely to have\never received OAT with methadone, and had used heroin (aOR X.XX,\n95%CI:X.XX, X.XX) and other pharmaceutical opioids in the month prior\n(aOR X.XX, 95%CI:X.XX, X.XX) (@fig-forest). Participants who preferred\nbuprenorphine were more likely to have ever received OAT with\nburpenorphine (aOR X.XX, 95%CI:X.XX, X.XX).\n\n![Forest plot of sociodemographic and drug use-related factors\nassociations with a preference for\nmethadone](figures/forest_plot_all.png){#fig-forest}\n\nParticipants who were currently receiving OAT and who preferred\nmethadone were more likely to have ever received OAT with methadone, and\nhad used heroin (aOR X.XX, 95%CI:X.XX, X.XX) and other pharmaceutical\nopioids in the past month (aOR X.XX, 95%CI:X.XX, X.XX) (@fig-forest).\nParticipants who preferred buprenorphine were more likely to have ever\nreceived OAT with burpenorphine (aOR X.XX, 95%CI:X.XX, X.XX).\n\n![Forest plot of sociodemographic and drug use-related factors\nassociations with a preference for methadone among participants\ncurrently receiving OAT](figures/forest_plot_oat.png){#fig-forest_oat}\n\n## Discussion\n\n### Limitations\n\n\n\n## Conclusion\n\n\n\\pagebreak\n\n## References\n\n\\singlespacing\n\n::: {#refs}\n:::\n\n\\pagebreak\n\n## Supplementary Material {#sec-supp-material}\n\n### Table S1\n",
    "supporting": [
      "index_files\\figure-html"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {
      "include-in-header": [
        "<script src=\"site_libs/kePrint-0.0.1/kePrint.js\"></script>\n<link href=\"site_libs/lightable-0.0.1/lightable.css\" rel=\"stylesheet\" />\n"
      ]
    },
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}